NCT06173609

Brief Summary

To assess the effect of LIMA patch as a method for the reconstruction on diffusely diseased LAD in the early and midterm outcomes

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 15, 2023

Completed
17 days until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

December 15, 2023

Status Verified

December 1, 2023

Enrollment Period

1 year

First QC Date

December 8, 2023

Last Update Submit

December 8, 2023

Conditions

Keywords

CABGLIMA

Outcome Measures

Primary Outcomes (1)

  • assess the effect of LIMA patch as a method for the reconstruction on diffusely diseased LAD in the early and midterm outcomes

    asses postoperative new arrhythmia//use of Inotropes// second session of surgery

    first week postoperative

Interventions

CABGPROCEDURE

During coronary artery bypass surgery, the surgeon removes a piece of blood vessel from the leg, chest, arm, or belly. Then, the surgeon uses that piece of blood vessel (called a "graft") to reroute blood around the blocked artery.

Eligibility Criteria

Age30 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Perioperative data values were coded, processed and collected in tables. Qualitative data were described using number and percent. Quantitative data were described using median and standard deviation. Statistical significance was assumed if a p value of 0.05 or less was achieved.

You may qualify if:

  • Any patient male,( or female) and his(or her) age from 30-90 years have Ischemic Heart Disease for CABG with diffusely diseased LAD.

You may not qualify if:

  • Any patient performed open heart surgery before

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Todorov IP, Todorova ZP, Nikolov DP. Angioplasty balloon occlusion of LIMA graft in reoperations of patients with prosthetic valve endocarditis and patent LIMA-LAD graft. Kardiochir Torakochirurgia Pol. 2022 Dec;19(4):199-204. doi: 10.5114/kitp.2022.122089. Epub 2022 Dec 24.

    PMID: 36643344BACKGROUND
  • Yang T, Yuan X, Li B, Zhao S, Sun H, Lu M. Long-term outcomes after coronary artery bypass graft with or without surgical ventricular reconstruction in patients with severe left ventricular dysfunction. J Thorac Dis. 2023 Apr 28;15(4):1627-1639. doi: 10.21037/jtd-22-1214. Epub 2023 Mar 23.

    PMID: 37197557BACKGROUND

Study Officials

  • Sameh Abdelrahman, professor

    Professor of Cardiothoracic surgery

    STUDY CHAIR
  • Ahmed Mohamed Taha, professor

    Professor of Cardiothoracic surgery

    PRINCIPAL INVESTIGATOR
  • Mohammed Hasan Osman, professor

    Professor of General surgery Maxillofacial surgery

    STUDY DIRECTOR

Central Study Contacts

Marwan Ahmed Mohamed, resident doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

December 8, 2023

First Posted

December 15, 2023

Study Start

January 1, 2024

Primary Completion

January 1, 2025

Study Completion

December 1, 2025

Last Updated

December 15, 2023

Record last verified: 2023-12